- A New Leader Continues to Strengthen IPS’ Global Process Services Offering -
Blue Bell, Pennsylvania, & Dublin, Ireland, May 21, 2020 – IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, is pleased to announce the appointment of Mr. Kevin Smyth to the position of Global Director of Process Technology.
Mr. Smyth, an industry-recognized subject matter expert based in IPS’ Dublin, Ireland office, will help lead the growth of the company’s Global Strategy and Technology (GS&T) group in the EMEA region. He is a chartered chemical engineer with 30 years’ experience in the design and operation of biopharmaceutical manufacturing facilities.
He has led over a hundred large molecule biologics, vaccines, and sterile fill-finish projects, from master planning, feasibility studies through detailed design. He is an expert in facility design and technology evaluation, including biological and high potent containment in a CGMP production environment.
Mr. Smyth has worked as a Subject Matter Expert (SME) on significant pharmaceutical projects across an ever-evolving regulatory compliance landscape. Clients he has supported include Allergan, Amgen, Abbott, Allergan, AbbVie, Bayer, Biocon, BMS, CSL, Eli Lilly, GE, MSD, Merck, Novartis, Pfizer, Sanofi, Takeda, and WuXi.
“It is difficult to find well-known subject matter experts like Kevin Smyth. We are delighted to have Kevin join our organization and help our mission to make a difference in the life science industry,” said Dave Goswami, PE, IPS Chairman and Chief Executive Officer. “Consistent with our vision to be the premier global knowledge provider in the industry, the addition of Kevin to our team of global experts reconfirms our leadership position. His blend of biologics and aseptic expertise will surely benefit our clients looking to bring their valuable products to market.”